MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action-Reference-Cited by-同舟云学术

MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action

Published:2012-02-20 Issue:7 Volume:188 Page:3088-3098
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Caproni Elena,Tritto Elaine,Cortese Mario,Muzzi Alessandro,Mosca Flaviana,Monaci Elisabetta,Baudner Barbara,Seubert Anja,De Gregorio Ennio

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.;Fiore;MMWR Recomm. Rep.,2008

2. A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children

3. Influenza Vaccine: Split-Product versus Whole-Virus Types — How Do They Differ?

4. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials

5. Plasmacytoid Dendritic Cells Delineate Immunogenicity of Influenza Vaccine Subtypes

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens;Exploration of Drug Science;2024-04-29

2. Vaccine adjuvants: Tailoring innate recognition to send the right message;Immunity;2024-04

3. Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer;Science Advances;2024-03-08

4. Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions;Cell & Bioscience;2024-02-17

5. Overview of Nanovaccines and Nanoadjuvants;Livestock Diseases and Management;2024